Neuronetics Q2 EPS $(0.17) Beats $(0.35) Estimate, Sales $17.61M Beat $17.38M Estimate
Portfolio Pulse from bharat@benzinga.com
Neuronetics (NASDAQ:STIM) reported Q2 earnings per share of $(0.17), beating the analyst consensus estimate of $(0.35) by 51.43%. This is a 56.41% increase over losses from the same period last year. The company also reported quarterly sales of $17.61 million, beating the analyst consensus estimate of $17.38 million by 1.32%, a 7.84% increase over sales from the same period last year.
August 08, 2023 | 11:34 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Neuronetics reported better than expected Q2 earnings and sales, which could positively impact its stock price.
Neuronetics reported Q2 earnings and sales that beat analyst estimates. This positive financial performance could lead to increased investor confidence and a potential rise in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100